Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,

Transparency Market Research includes new market research report “Enteric Disease Testing Market" to its huge collection of research reports.
Spread the Word
Listed Under

Transparency Market Research
Market Research Reports
Enteric Disease Testing Market


Albany - New York - US

ALBANY, N.Y. - June 17, 2014 - PRLog -- According to a new market report published by Transparency Market Research, "Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global enteric disease testing market was valued at USD 3.1 billion in 2012 and is expected to grow at a CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6 billion in 2019.

Browse the Enteric Disease Testing Market full report with complete TOC at http://www.transparencymarketresearch.com/enteric-disease-testing-market.html

Enteric diseases are major causes of morbidity and mortality worldwide. Developing socio-economic countries with poor drainage, sanitation along with overcrowding and low hygiene awareness account for majority of enteric infection incidences prevailing worldwide. These diseases usually exhibit mild symptoms but if not treated on time can lead to severe complications, resulting in death. In order to manage these diseases effectively, their early detection is essential. Various enteric diseases responsible for diarrhea, stomach pain, nausea, vomiting, anorexia, weight loss and fever are amebiasis, giardiasis, rotavirus infection, salmonellosis and shigellosis.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.p...

Traditionally, diagnosis of enteric infections relied on culture results of fecal specimen. Today, the world is witnessing a paradigm shift from culture to EIA (enzyme immunoassaya) and PCR (polymerase chain reaction) based tests owing to advantages associated with these newer testing methods. EIA and PCR tests offer enhanced sensitivity and specificity compared to culture tests and also give quick results. Globally the market for enteric disease testing is growing at a CAGR of 2.4% under the influence of rising awareness, demand for point of care testing and increasing application of molecular diagnostics. Use of molecular diagnostic products has made diagnosis easy and possible, even those strains which once seemed to be difficult and impossible. North America and Europe represent the largest regional markets because valwy of rapid demand for molecular based diagnostics and due to high level of awareness among people about the diseases. C.difficile infection is one of the major causes of antibiotic related diarrhea in developed regions.

Browse all Pharmaceutical Market Research Reports @http://www.transparencymarketresearch.com/pharmaceutical-...

Various epidemiological sources including CDC and American Association for Clinical Chemistry suggest that C.difficile infection incidence per 100,000 people has increased over the past few decades in United States. In developing nations, frequent travelling to regions where enteric diseases are epidemic is also one of the reasons driving the market growth. Asia-Pacific and Africa have been predicted to grow rapidly during the forecast period. In developing nations of Asia-pacific, Africa and Latin America, the market is also growing due to advent of rapid dipstick tests which can be applied by the patient themself. These regions associated with inadequate healthcare infrastructure do not possess substantial number of laboratories to perform laboratory based tests. Thus, rapid dipstick test kits being inexpensive and easy to use are widely accepted in these regions for managing enteric illness. Continuously improving economy and rising healthcare expenditure in these regions are also anticipated to drive the market. The market is also growing due to emergence of new strains; sources from Eurosurveillance suggest that the norovirus infection is increasing worldwide, including United Kingdom, the Netherlands, France, Japan and Australia due to emergence of new strain of genotype II.4 (GII.4) that is also known as Sydney strain.

Browse Blog http://tmrresearch.wordpress.com/

Transparency Market Research
Posted By:***@transparencymarketresearch.com Email Verified
Tags:Transparency Market Research, Market Research Reports, Pharmaceutical, Enteric Disease Testing Market
Industry:Health, Medical
Location:Albany - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Transparency Market Research PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share